Recently, a research report published in the international journal Science Immunology, scientists from the University of Colorado found that the disease-resistant T cells obtained from the vaccine may not need glucose to rapidly multiply, related research results may provide new ideas and hopes for the development of new immunotherapy for cancer patients. https://www.creative-bioarray.com/products/tumor-cell-types-13.htm
BioprocessingInformatics